Latest news

1 week ago

Addressing the addiction and mental health crises in the United States

3 months ago

Ibogaine and Noribogaine: Mechanisms and Therapeutic Potential as Addiction Medicines

3 months ago

Exploring the Future of VR and Digital Therapeutics

3 months ago

The Unparalleled Power of Ibogaine in Addiction Recovery With Tom Feegel, CEO of Beond

3 months ago

Breaking the Cycle of Addiction with Ibogaine

3 months ago

Ibogaine Receives Serious Media Attention

3 months ago

Powerful Psychedelic Gains Renewed Attention as a Treatment for Opioid Addiction

3 months ago

Psychedelics Today Ep. 448: Deborah C. Mash, Ph.D. – Ibogaine, Noribogaine, and the Challenges of Federal Drug Policy

3 months ago

Opium Addiction Market expected to rise – BioCorRx Inc, Delpor Inc, DemeRx Inc, Alar Pharmaceuticals, expected to drive market

3 months ago

Advocates of using psychedelic drug ibogaine to treat addiction say its risks to the heart can be mitigated in a controlled study